Curr Opin Virol

• 

  Publication Venue For

  • From high-throughput to therapeutic: host-directed interventions against influenza viruses..  53:101198. 2022
  • Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination..  51:172-178. 2021
  • Cytomegalovirus as an immunomodulator across the lifespan..  44:112-120. 2020
  • Harnessing virus tropism for dendritic cells for vaccine design..  44:73-80. 2020
  • Risk factors and biomarkers of severe dengue..  43:1-8. 2020
  • Reprogramming of cellular metabolic pathways by human oncogenic viruses..  39:60-69. 2019
  • Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections..  25:126-133. 2017
  • Protect this house: cytosolic sensing of viruses..  22:36-43. 2017
  • Cellular transduction mechanisms of adeno-associated viral vectors..  21:54-60. 2016
  • Engineering AAV receptor footprints for gene therapy..  18:89-96. 2016
  • Selection of HIV vaccine candidates for concurrent testing in an efficacy trial..  17:57-65. 2016
  • Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus..  13:81-85. 2015
  • Herpesvirus microRNAs: phenotypes and functions..  1:211-215. 2011